These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 26392499)

  • 1. Effect of Preexposure to Triazoles on Susceptibility and Virulence of Rhizopus oryzae.
    Bellanger AP; Albert ND; Lewis RE; Walsh TJ; Kontoyiannis DP
    Antimicrob Agents Chemother; 2015 Dec; 59(12):7830-2. PubMed ID: 26392499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative in vitro activities of posaconazole, voriconazole, itraconazole, and amphotericin B against Aspergillus and Rhizopus, and synergy testing for Rhizopus.
    Arikan S; Sancak B; Alp S; Hascelik G; McNicholas P
    Med Mycol; 2008 Sep; 46(6):567-73. PubMed ID: 19180726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Voriconazole pre-exposure selects for breakthrough mucormycosis in a mixed model of Aspergillus fumigatus-Rhizopus oryzae pulmonary infection.
    Lewis RE; Liao G; Wang W; Prince RA; Kontoyiannis DP
    Virulence; 2011; 2(4):348-55. PubMed ID: 21788730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preexposure to Isavuconazole Increases the Virulence of
    Wurster S; Lewis RE; Albert ND; Kontoyiannis DP
    Antimicrob Agents Chemother; 2019 Feb; 63(2):. PubMed ID: 30455245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular basis for enhanced activity of posaconazole against Absidia corymbifera and Rhizopus oryzae.
    Chau AS; Chen G; McNicholas PM; Mann PA
    Antimicrob Agents Chemother; 2006 Nov; 50(11):3917-9. PubMed ID: 16966400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tacrolimus enhances the potency of posaconazole against Rhizopus oryzae in vitro and in an experimental model of mucormycosis.
    Lewis RE; Ben-Ami R; Best L; Albert N; Walsh TJ; Kontoyiannis DP
    J Infect Dis; 2013 Mar; 207(5):834-41. PubMed ID: 23242544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of Posaconazole against Rhizopus oryzae Infection in Silkworm.
    Kurakado S; Matsumoto Y; Sugita T
    Med Mycol J; 2021; 62(3):53-57. PubMed ID: 34471035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro antifungal susceptibility of clinical species belonging to Aspergillus genus and Rhizopus oryzae.
    Kachuei R; Khodavaisy S; Rezaie S; Sharifynia S
    J Mycol Med; 2016 Mar; 26(1):17-21. PubMed ID: 26852191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased virulence of Zygomycetes organisms following exposure to voriconazole: a study involving fly and murine models of zygomycosis.
    Lamaris GA; Ben-Ami R; Lewis RE; Chamilos G; Samonis G; Kontoyiannis DP
    J Infect Dis; 2009 May; 199(9):1399-406. PubMed ID: 19358672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperthermia sensitizes Rhizopus oryzae to posaconazole and itraconazole action through apoptosis.
    Shirazi F; Pontikos MA; Walsh TJ; Albert N; Lewis RE; Kontoyiannis DP
    Antimicrob Agents Chemother; 2013 Sep; 57(9):4360-8. PubMed ID: 23817366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitochondrial respiratory pathways inhibition in Rhizopus oryzae potentiates activity of posaconazole and itraconazole via apoptosis.
    Shirazi F; Kontoyiannis DP
    PLoS One; 2013; 8(5):e63393. PubMed ID: 23696824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular Confirmation of the Linkage between the
    Macedo D; Leonardelli F; Dudiuk C; Theill L; Cabeza MS; Gamarra S; Garcia-Effron G
    Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29891608
    [No Abstract]   [Full Text] [Related]  

  • 13. A Revised Species Concept for Opportunistic
    Wagner L; de Hoog S; Alastruey-Izquierdo A; Voigt K; Kurzai O; Walther G
    Antimicrob Agents Chemother; 2019 Aug; 63(8):. PubMed ID: 31182532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro and in vivo activities of posaconazole against zygomycetes with various degrees of susceptibility.
    Spreghini E; Orlando F; Giannini D; Barchiesi F
    J Antimicrob Chemother; 2010 Oct; 65(10):2158-63. PubMed ID: 20667887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro susceptibility testing of Aspergillus spp. against voriconazole, itraconazole, posaconazole, amphotericin B and caspofungin.
    Shi JY; Xu YC; Shi Y; Lü HX; Liu Y; Zhao WS; Chen DM; Xi LY; Zhou X; Wang H; Guo LN
    Chin Med J (Engl); 2010 Oct; 123(19):2706-9. PubMed ID: 21034656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How does antifungal pharmacology differ for mucormycosis versus aspergillosis?
    Lewis RE; Lortholary O; Spellberg B; Roilides E; Kontoyiannis DP; Walsh TJ
    Clin Infect Dis; 2012 Feb; 54 Suppl 1():S67-72. PubMed ID: 22247448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In Vitro Susceptibility Profiles of Eight Antifungal Drugs against Clinical and Environmental Strains of Phaeoacremonium.
    Badali H; Khodavaisy S; Fakhim H; de Hoog GS; Meis JF; Chowdhary A
    Antimicrob Agents Chemother; 2015 Dec; 59(12):7818-22. PubMed ID: 26369976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activities of posaconazole, fluconazole, itraconazole, voriconazole, and amphotericin B against a large collection of clinically important molds and yeasts.
    Sabatelli F; Patel R; Mann PA; Mendrick CA; Norris CC; Hare R; Loebenberg D; Black TA; McNicholas PM
    Antimicrob Agents Chemother; 2006 Jun; 50(6):2009-15. PubMed ID: 16723559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Posaconazole combined with amphotericin B, an effective therapy for a murine disseminated infection caused by Rhizopus oryzae.
    Rodríguez MM; Serena C; Mariné M; Pastor FJ; Guarro J
    Antimicrob Agents Chemother; 2008 Oct; 52(10):3786-8. PubMed ID: 18694953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Posaconazole prophylaxis in experimental systemic zygomycosis.
    Barchiesi F; Spreghini E; Santinelli A; Fothergill AW; Pisa E; Giannini D; Rinaldi MG; Scalise G
    Antimicrob Agents Chemother; 2007 Jan; 51(1):73-7. PubMed ID: 17060525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.